Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-22-015811

EVP and Chief Legal Officer sold 2,886 shares at $66.62 ($192,265)

  • EVP and Chief Legal Officer acquired 14,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Parschauer Karah Herdman · EVP and Chief Legal Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-01 Sale : show line 1 in the form −2,886 $66.62 $192,265 25,472 D
2022-03-01 Grant or award : show line 2 in the form +14,000 39,578 D
Open-market sales · 2,886 sh · avg $66.62 · $192,265

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-03-01 Grant or award : show line 3 in the form Stock Option (Right to Buy) +24,900 24,900 D
Loading xslF345X03/doc4.xml…